Consistent with the predicted role of KDM5C as a transcriptional repressor through removing the histone activation marker H3K4me3, our results revealed that FASN is targeted directly by KDM5C during the progression of ICC. The gene discussed is KDM5C; the disease is intrahepatic cholangiocarcinoma.